Breathett, Khadijah

2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction

Maddox, T. M., Januzzi, J. L., Allen, L. A., Breathett, K., Brouse, S., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Lindenfeld, J., et al. (2024) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementCardiac pacing and defibrillation studies

Cited by 362

Racial and ethnic differences in bystander CPR for witnessed cardiac arrest

Garcia, R. A., Spertus, J. A., Girotra, S., Nallamothu, B. K., Kennedy, K. F., McNally, B. F., Breathett, K., Del Rios, M., Sasson, C., & Chan, P. S. (2022) · New England Journal of Medicine

Cardiac Arrest and ResuscitationPalliative Care and End-of-Life Issues

Cited by 163

Stress, Resilience, and Cardiovascular Disease Risk Among Black Women: Results From the Women’s Health Initiative

Felix, A. S., Lehman, A., Nolan, T. S., Sealy-Jefferson, S., Breathett, K., Hood, D. B., Addison, D., Anderson, C. M., Cené, C. W., Warren, B. J., et al. (2019) · Circulation: Cardiovascular Quality and Outcomes

Cardiac Health and Mental HealthResilience and Mental Health

Cited by 101

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome

Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC

Diabetes, Cardiovascular Risks, and LipoproteinsChronic Kidney Disease and Diabetes

Cited by 90

Risk-based primary prevention of heart failure: a scientific statement from the American Heart Association

Khan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., et al. (2025) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 75

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes

Essien, U. R., Singh, B., Swabe, G., Johnson, A. E., Eberly, L. A., Wadhera, R. K., Breathett, K., Vaduganathan, M., & Magnani, J. W. (2023) · JAMA Network Open

Medication Adherence and ComplianceDiabetes Treatment and Management

Cited by 69

Controversies and Conundrums in Cardiac Cachexia

Ilonze, O. J., Parsly Read-Button, L., Cogswell, R., Hackman, A., Breathett, K., Saltzman, E., & Vest, A. R. (2024) · JACC: Heart Failure

Nutrition and Health in AgingHeart Failure Treatment and Management

Cited by 30

Taking action to advance the study of race and ethnicity: the Women’s Health Initiative (WHI).

Garcia, L., Follis, S., Thomson, C. A., Breathett, K., Cené, C. W., Jimenez, M., Kooperberg, C., Masaki, K., Paskett, E. D., Pettinger, M., et al. (2022) · Women's Midlife Health

Race, Genetics, and SocietyRacial and Ethnic Identity Research

Cited by 29

2025 AHA/ACC Statement on Cost/Value Methodology in Clinical Practice Guidelines (Update From 2014 Statement)

Kazi, D. S., Abdullah, A. R., Arnold, S. V., Basu, A., Bellows, B. K., Breathett, K., Chew, D. S., Cohen, D. J., DeJong, C., Heidenreich, P. A., et al. (2026) · JACC

Health Systems, Economic Evaluations, Quality of LifeClinical practice guidelines implementation

Cited by 14